Jay Vision Care And Ophthalmics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -96.15%
(FY 2023)
- Profit -36.96%
(FY 2023)
- Ebitda 102.53%
(FY 2023)
- Net Worth -105.62%
(FY 2023)
- Total Assets -94.19%
(FY 2023)
About Jay Vision Care And Ophthalmics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jay Vinod and Neelam Goyel serve as directors at the Company.
- CIN/LLPIN
U85110MH2002PTC134664
- Company No.
134664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jay Vision Care And Ophthalmics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Vinod  | Director | 26-Oct-2023 | Current |
| Neelam Goyel | Director | 23-Jan-2002 | Current |
Financial Performance of Jay Vision Care And Ophthalmics.
Jay Vision Care And Ophthalmics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.15% decrease. The company also saw a substantial fall in profitability, with a 36.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Vision Care And Ophthalmics?
In 2023, Jay Vision Care And Ophthalmics had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surya Eye Institute & Research Centre Private LimitedActive 28 years 1 monthJay Vinod and Neelam Goyel are mutual person
C-Quick Lasik Laser Centre Private LimitedActive 8 years 4 monthsJay Vinod and Neelam Goyel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jay Vision Care And Ophthalmics?
Unlock and access historical data on people associated with Jay Vision Care And Ophthalmics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Vision Care And Ophthalmics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Vision Care And Ophthalmics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
